Guido Junge

Company: Novartis AG

Job title: Head of Transverse Myelitis Autoimmunity, Renal & Transplantation

Seminars:

3:30 PM Panel Discussion and Q&A: Navigating Global Partnerships, Funding Strategies & Value Demonstration in the Rare & Genetic Kidney Disease Field

Delving into challenges and best practices for safeguarding intellectual property during global collaboration efforts in the development and commercialization of therapies for renal disease Addressing the reluctance in conducting head-to-head trials Exploring alternative strategies for demonstrating clinical and economic value of novel drug mechanisms compared to existing treatment options Discussing innovative funding models, partnership strategies…Read more

day: Conference Day 2

2:00 PM Revolutionizing Clinical Trial Design for IgA Nephropathy to Overcome Challenges Associated with Slow Disease Progression 2:00 pm

Exploring surrogate endpoints beyond GFR to capture changes in disease activity earlier in progression Advancing innovative trial designs with flexible durations and interim analyses to solidify the evaluation of therapeutic efficacy Applying emerging and established biomarkers to identify a variety of patient subgroups for targeted enrolment resulting in small, efficient trialsRead more

day: Conference Day 1

3:30 PM Panel Discussion: Lessons Learnt from Successful Clinical Trials in IgAN & C3G to Inform Successful Clinical Design & Development in Wider Rare & Genetic Kidney Diseases 3:30 pm

Advancing understanding of disease pathophysiology and biomarker identification to guide the development of therapies with distinguished mechanism of actions Discussing suitable design of placebo arm and standard of care for rare diseases Examining the importance of integrating patient-reported outcomes, quality of like measures and comparative effectiveness research early in clinical development to demonstrate meaningful differentiationRead more

day: Conference Day 1